Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
05/2003
05/27/2003US6569622 Nucleic acids encoding a protein conferring an inducible resistance to glycopeptide, particularly in gram-positive bacteria
05/27/2003US6569617 Identifying a chemical agent which alters activity of a protein encoded by a mammalian gene, modifying the phenotypic alteration
05/27/2003US6569434 Vascular endothelial cell growth factor C subunit
05/27/2003US6569429 Isolated polypeptide comprising the amino acid residues 1 to 344 of (SEQ ID NO: 2); systemic lupus erythematosus; pulmonary disease or disorder
05/27/2003US6569422 Genetically engineered cell culture adapted infectious bursal diseases virus (IBDV) mutants
05/27/2003US6569420 Human interferon-ε: a type I interferon
05/27/2003CA2179208C Human cns receptor polynucleotides
05/27/2003CA2158455C Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide and their uses in vaccines and disease treatments
05/27/2003CA2152963C A process for producing immunosuppressives and a novel microbial species to be employed therein
05/27/2003CA2096230C Characterization of platelet aggregation disorders
05/27/2003CA2031430C Process for refolding recombinantly produced tgf-.beta.-like proteins
05/27/2003CA2024309C Pharmaceutical compositions comprising modified and unmodified plasminogen activators and uses thereof
05/27/2003CA1341429C Hirudin variants, their use and processes for obtaining them
05/22/2003WO2003042412A1 Reca-negative and rhab-negative microorganism
05/22/2003WO2003042401A2 Novel chromophores/fluorophores and methods for using the same
05/22/2003WO2003042399A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
05/22/2003WO2003042367A2 Antibodies that immunospecifically bind to trail receptors
05/22/2003WO2003042366A2 A novel saitohin gene and uses of same
05/22/2003WO2003042363A2 Eit-6, a polypeptide encoded by an estrogen regulated gene
05/22/2003WO2003042362A2 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
05/22/2003WO2003042359A2 Histamine receptor h3 polynucleotides
05/22/2003WO2003042357A2 Enzymes
05/22/2003WO2003042344A2 Apo2 ligand/trail formulations
05/22/2003WO2003042249A2 Peptide purification by means of metal ion affinity chromatography
05/22/2003WO2003042247A2 Modified anti-tnf alpha antibody
05/22/2003WO2003042245A2 Growth hormone variations in humans and their uses
05/22/2003WO2003042240A2 Polypeptides of pseudomonas aeruginosa
05/22/2003WO2003042233A2 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry
05/22/2003WO2003020763A3 Soluble t cell receptor
05/22/2003WO2003016464A3 Cancer specific oligosaccharide sequences and use thereof
05/22/2003WO2002102836A3 Moraxella (branhamella) catarrhalis antigens
05/22/2003WO2002090533A3 Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells
05/22/2003WO2002078766A3 Combination therapy
05/22/2003WO2002072036A3 Compositions and methods comprising west nile virus polypeptides
05/22/2003WO2002023202A3 Method to identify antibody targets based on mass spectrometry (maldi-tof)
05/22/2003WO2002022776A9 Human coagulation factor vii variants
05/22/2003WO2001068708A9 Human and humanized fap-alpha-specific antibodies
05/22/2003US20030096982 Nucleotide sequences coding polypeptide for use in the treatment of immunological, reproductive and liver disorders
05/22/2003US20030096977 Antibody against human interleukin-5 receptor alpha chain
05/22/2003US20030096973 Recombinant collagens and derived proteins produced by plants, methods of obtaining such and their uses
05/22/2003US20030096970 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/22/2003US20030096969 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/22/2003US20030096967 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096965 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096964 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/22/2003US20030096963 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096956 Process for producing kiss-1 peptide
05/22/2003US20030096955 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer and nervous system disorders
05/22/2003US20030096954 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer and nervous system disorders
05/22/2003US20030096948 Acylating a destryptophan compound to obtain an ornithin amino protected compound, removing the ornithine protecting group; antibiotic daptomycin stereoisomeric compounds
05/22/2003US20030096765 Aromatic esters; cytotoxic agents; antitumor agents
05/22/2003US20030096749 Human cytokine receptor
05/22/2003US20030096744 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096742 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096738 Peptide vector
05/22/2003US20030096402 Chemically defined medium for cultured mammalian cells
05/22/2003US20030096388 Proteinase inhibitor, precursor thereof and genetic sequences encoding same
05/22/2003US20030096386 Nuclelotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorder
05/22/2003US20030096373 Antibody for use in the detection of tumors
05/22/2003US20030096372 Culture medium for culture of animal cell and method for producing protein using same
05/22/2003US20030096370 Gram negative bacterial protein for use in the prevention and treatment of bacterial infection
05/22/2003US20030096368 Nucleotide sequences coding bactericide for use in the treatment and prevention of neisseria infections
05/22/2003US20030096364 Nuclelotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorder
05/22/2003US20030096362 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096359 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096358 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096357 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096352 Nucleotide sequences coding polypeptides for use in the treatment and prevention of viral and bacterial disease
05/22/2003US20030096351 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/22/2003US20030096348 DNA molecules encoding mammalian nuclear receptor protein, nNR5
05/22/2003US20030096346 Nucleic acids, proteins, and antibodies
05/22/2003US20030096340 Nucleotide sequences coding polypeptide for use in the treatment, diagnosi and prevention of skin, kidney and cell proliferative disorders
05/22/2003US20030096338 Protein conjugate for use in the treatment of blood disorder
05/22/2003US20030096335 Nucleic acid fragment and vector comprising a halogenase, and a process for halogenating chemical compounds
05/22/2003US20030096312 Novel natrium-calcium exchanger protein
05/22/2003US20030096306 Intrabodies with defined framework that is stable in a reducing environment and applications thereof
05/22/2003US20030096301 Linker for solid-phase synthesis
05/22/2003US20030096296 Detect compound which binds to bone morphogenic protein receptors; obtain sample, incubate with binding agent, allow binding, detect complex formation between binding agent and receptors
05/22/2003US20030096285 Detection of targets for anticarcinogenic agents; obtain tumor cells, determine protein expression pattern, compare to wild type, isolate differentially expessed proteins, use protein as diagnostic tool
05/22/2003US20030096281 Generation of preferential biopolymers; obtain chemical intermediates, incubate with preferential enzymes, recover reaction product
05/22/2003US20030096279 Nuccleotide sequences coding polypeptide for use in the treatment of nervous system disorders
05/22/2003US20030096250 Nucleotide sequences coding polypeptide for use in the prevention of bacterial infection of mammals
05/22/2003US20030096247 Human cDNAs and proteins and uses thereof
05/22/2003US20030096234 Monitoring preferential gene expression profile; obtain cellsample, incubate with modulator, monitor gene expression profile, compare to control, evaluate gene expression
05/22/2003US20030096233 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096226 Use of a native epitope for selecting evolved binding members from a library of mutants of a protein capable of binding to said epitope
05/22/2003US20030096225 Recovering preferential protein from library; obtain cell, transform with vector, express vector, isolate preferential protein
05/22/2003US20030095986 Production of a parvovirus vaccine in plants as viral coat protein fusions
05/22/2003US20030095976 Methods to improve immunogenicity of antigens and specificity of antibodies
05/22/2003US20030095973 Chlamydia antigens and corresponding DNA fragments and uses thereof
05/22/2003US20030095964 Process for producing humanized chimera antibody
05/22/2003US20030095963 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restriced differentiation antigen for treatment of B cell lymphoma
05/22/2003CA2784450A1 Polypeptides of pseudomonas aeruginosa
05/22/2003CA2467347A1 Histamine receptor h3 polynucleotides
05/22/2003CA2466592A1 Modified anti-tnf alpha antibody
05/22/2003CA2466521A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
05/22/2003CA2466420A1 A novel saitohin gene and uses of same
05/22/2003CA2466415A1 Pgc-1.beta., a novel pgc-1 homologue and uses therefor
05/22/2003CA2465912A1 Eit-6, a polypeptide encoded by an estrogen regulated gene
05/22/2003CA2465214A1 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry
1 ... 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 ... 1125